147 related articles for article (PubMed ID: 17234182)
1. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance.
Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M
Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells.
Cimbora-Zovko T; Fritz G; Mikac N; Osmak M
Cancer Lett; 2010 Sep; 295(2):182-90. PubMed ID: 20303648
[TBL] [Abstract][Full Text] [Related]
3. Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage.
Fuchs M; Hermannstädter C; Hutzler P; Häcker G; Haller F; Höfler H; Luber B
Exp Cell Res; 2008 Jan; 314(1):153-63. PubMed ID: 17959171
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive alteration of the cell-cell adhesion in head and neck squamous cell cancer.
Naim R; Chang RC; Schultz J; Hormann K
Oncol Rep; 2006 Aug; 16(2):273-7. PubMed ID: 16820902
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation and altered localization of gamma-catenin in cisplatin-resistant adenocarcinoma cells.
Liang XJ; Shen DW; Gottesman MM
Mol Pharmacol; 2004 May; 65(5):1217-24. PubMed ID: 15102950
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin-dependent intercellular adhesion enhances chemoresistance.
Nakamura T; Kato Y; Fuji H; Horiuchi T; Chiba Y; Tanaka K
Int J Mol Med; 2003 Nov; 12(5):693-700. PubMed ID: 14532995
[TBL] [Abstract][Full Text] [Related]
7. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
8. Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1.
Aktary Z; Chapman K; Lam L; Lo A; Ji C; Graham K; Cook L; Li L; Mackey JR; Pasdar M
Oncogene; 2010 Apr; 29(14):2118-29. PubMed ID: 20101217
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of endothelial beta-catenin and plakoglobin during development and maturation of the blood-brain and blood-retina barrier in the chicken.
Liebner S; Gerhardt H; Wolburg H
Dev Dyn; 2000 Jan; 217(1):86-98. PubMed ID: 10679932
[TBL] [Abstract][Full Text] [Related]
12. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns.
Beketić-Oresković L; Osmak M
Neoplasma; 1994; 41(3):171-6. PubMed ID: 7935986
[TBL] [Abstract][Full Text] [Related]
13. The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin.
Chekhun VF; Lukyanova NY; Urchenko OV; Kulik GI
Exp Oncol; 2005 Sep; 27(3):191-5. PubMed ID: 16244579
[TBL] [Abstract][Full Text] [Related]
14. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
15. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
16. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
Stordal BK; Davey MW; Davey RA
Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
20. Codominance of cisplatin resistance in somatic cell hybrids.
Ying YL; Shen DW; Liang XJ; Gottesman MM
J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
